Citadel Advisors’s Benessere Capital Acquisition Corp. Class A Common Stock BENE Stock Holding History

Citadel Advisors’s Portfolio BENE Stock Details BENE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-136,300	Closed	-$1.4M	–	14723
2022 Q1	$1.4M	Sell	136,300 -614,900	-82%	-$6.28M	﹤0.01%	6901
2021 Q4	$7.62M	Buy	+751,200	New	+$7.78M	﹤0.01%	3546

Citadel Advisors's BENE Position: Q1 2022 in Review

Citadel Advisors sold out of Benessere Capital Acquisition Corp. Class A Common Stock (BENE) in Q1 2022, closing a stake of 687,485 shares — an estimated $7.02M sold.

Citadel Advisors first reported a position in BENE in Q4 2021 and held it in 1 quarter. The position peaked at $6.97M in Q4 2021. 36 funds tracked by Wall St. Rank hold BENE as of Q1 2022.

Citadel Advisors reported no remaining Benessere Capital Acquisition Corp. Class A Common Stock position as of Q1 2022 after selling out during the quarter.
Citadel Advisors sold 687,485 Benessere Capital Acquisition Corp. Class A Common Stock shares in Q1 2022, an estimated $7.02M.
Citadel Advisors first reported a position in Benessere Capital Acquisition Corp. Class A Common Stock in Q4 2021 and held it in 1 quarter.
Citadel Advisors's Benessere Capital Acquisition Corp. Class A Common Stock position peaked at $6.97M in Q4 2021.
36 funds tracked by Wall St. Rank held Benessere Capital Acquisition Corp. Class A Common Stock as of Q1 2022.

Based on Citadel Advisors's 13F filing for Q1 2022, filed 16 May 2022.